Great work to management and LT shareholders that maintained full confidence in the company through the recent SP weakness. Also, congrats to new holders who saw the huge opportunity with recent prices!
I think the sexist arguments towards Jayne can now be laid to rest (finally) - she is performing highly, and also responding to shareholder's concerns. I think Geoff B was replaced precisely at the right time - which gives me further confidence in the board.
Now that the Jayne has addressed the infrastructure, tech, employees and geographic growth & expansion (and people ask what she has been doing?!) - I believe the company will now look to utilise the cash reserves as well as focusing on new growth drivers (products) in coming months.
As always - we are still on the up and up.
- Forums
- ASX - By Stock
- A2M
- AgM update
AgM update, page-51
-
-
- There are more pages in this discussion • 162 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $8.091M | 1.172M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 9424 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 11149 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 8360 | 6.850 |
15 | 21499 | 6.840 |
19 | 50223 | 6.830 |
12 | 49212 | 6.820 |
11 | 79798 | 6.810 |
Price($) | Vol. | No. |
---|---|---|
6.860 | 15322 | 23 |
6.870 | 39702 | 15 |
6.880 | 60648 | 15 |
6.890 | 16563 | 11 |
6.900 | 33122 | 13 |
Last trade - 15.56pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online